Crowdonomics
New Entheogen Ltd

Reg CF · Preferred Stock · Feb 2025

ClosedReg CFPreferred Equity
via WeFunder · last checked Aug 17, 2026
Raised
$0 / $500K max
0% of ceiling
Investors
—
—
Valuation
—
—

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$61K
−$753K
FY2022
$4.2M
−$757K
FY2023
RevenueNet income
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$60,878
$4,180,700
Cost of goods sold
$67,176
$65,318
Gross margin
-10%
98%
Net income
-$752,552
-$757,149
Taxes paid
$0
$0
Balance sheet
Cash
$4,865
$44,785
Accounts receivable
$600
$0
Total assets
$45,903
$729,280
Short-term debt
$15,753
$157,904
Long-term debt
$375,200
$596,928
Total liabilities
$390,953
$754,832
Other
Headcount
—
2

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Apr 30, 2025
    • Deadline Apr 30, 2025 → Apr 30, 2026

    “Adding in 2024 financials and extending close date.”

    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Price / share$0.4631
Shares offered118,722

Offering details

Target$50,000
Max$500,000
Min investment—
OpenedFeb 20, 2025
DeadlineApr 30, 2026
ClosedApr 30, 2026
Days active434

Links & provenance

Source: SEC EDGAR
0001670254-25-000096
Last synced Aug 17, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.